Author

Kalliopi Foteinogiannopoulou 1

1 University Hospital of Heraklion,Heraklion,Greece

Effect of antinuclear antibodies on the pharmacokinetics of infliximab in patients with inflammatory bowel disease

eirini theodoraki, Eleni Orfanoudaki, Kalliopi Foteinogiannopoulou, Evangelia Legaki, Maria Gazouli, Ioannis Koutroubakis

EFFECTIVENESS OF THIRD-CLASS BIOLOGIC TREATMENT IN CROHN´S DISEASE: A MULTI-CENTER RETROSPECTIVE COHORT STUDY

Ahmad Albshesh, Joshua Taylor, Edoardo Vincenzo Savarino, Marie Truyens, Alessandro Armuzzi, Davide Giuseppe Ribaldone, Ariella Shitrit, Morine Fibelman, Pauliina Molander, Claire Liefferinckx, Stephane Nancy, Mohamed Korani, Klaudia Farkas, Manuel Barreiro de Acosta, Viktor Domislovic, Gerard Surís, Carl Eriksson, Catarin

EFFECTS OF COVID-19 ON EMPLOYMENT IN IBD PATIENTS

Trevor Tabone, Konstantinos Karmiris, Martina Sciberras, Penelope Nikolaou, Angeliki Theodoropoulou, Abigail Mula, Gerassimos J. Mantzaris, Tereza Deorgiadi, Kalliopi Foteinogiannopoulou, Ioannis Koutroubakis, Mariangela Allocca, Gionata Fiorino, Federica Furfaro, Konstantinos H. Katsanos, Fotis Fousekis, Georgios Michalopou

FACTORS ASSOCIATED WITH TREATMENT PERSISTENCE OF ANTI-TNF AGENTS AS FIRST LINE BIOLOGIC TREATMENT IN GREEK PATIENTS WITH INFLAMMATORY BOWEL DISEASES

Eleni Orfanoudaki, Eirini Theodoraki, Kalliopi Foteinogiannopoulou, Ioannis Drygiannakis, George Chlorakis, Maria Tsafaridou, Ioannis Koutroubakis

INFLIXIMAB TROUGH LEVELS AND ANTIBODIES TO INFLIXIMAB IN ASSOCIATION WITH DISEASE ACTIVITY AND MUCOSAL HEALING IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

Eleni Orfanoudaki, Maria Gazouli, Kalliopi Foteinogiannopoulou, eirini theodoraki, Evangelia Legaki, Ioannis Koutroubakis

MENTAL HEALTH, WORK PRESENTEEISM AND EXERCISE IN IBD PATIENTS

Martina Sciberras, Abigail Mula, Tereza Georgiadi, Fotios Fousekis, Penelope Nikolaou, Gerassimos J. Mantzaris, Hadar Amir, Catarina Nascimento, Pierre Ellul, Georgios Michalopoulos, Konstantinos Karmiris, Kalliopi Foteinogiannopoulou, Angeliki Theodoropoulou, Trevor Tabone, Ioannis Koutroubakis, Henit Yanai, Konstantinos H

The real world use of fecal calprotectin home testing in patients with inflammatory bowel disease under maintenance treatment with adalimumab

Eleni Orfanoudaki, eirini theodoraki, Kalliopi Foteinogiannopoulou, AIKATERINI MANTAKA, Ioannis Koutroubakis

THIRD-LINE THERAPY IN REFRACTORY ULCERATIVE COLITIS: A COMPARISON BETWEEN TOFACITINIB AND USTEKINUMAB

Mariangela Allocca, Gaia Catalano, Edoardo Vincenzo Savarino, María Chaparro, Asaf Levartovsky, Georgios Michalopoulos, Nikos Viazis, Fotios Fousekis, Andreas Psistakis, Daniele Noviello, Catarina Neto do Nascimento, Bénédicte Caron, Vassiliki Kitsou, Giorgos Bamias, María José García, Eirini Zacharopoulou, Kalliopi Foteino

TOFACITINIBFOR THETREATMENT OFMODERATE - SEVERE ULCERATIVE COLITIS. THE GREEK EXPERIENCE

Nikos Viazis, Dimitrios K. Christodoulou, OLGA GIOULEME, Angeliki Theodoropoulou, Giorgos Bamias, Evanthia Zampeli, Ioannis Koutroubakis, Maria Tzouvala, Konstantinos Karmiris, Ioanna Mousavere, Konstantinos H. Katsanos, Marios Katsaros, Vasiliki Kitsou, Georgios Axiaris, Spyridon Michopoulos, Kalliopi Foteinogiannopoulou,

Item 1 - 9 / 9
1